Page 11 - Nasdaq Regn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vectors Research Management LLC reduced its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,076 shares of the biopharmaceutical company’s stock after selling 13 shares during the quarter. Vectors […]

Texas Permanent School Fund Corp decreased its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 22,063 shares of the biopharmaceutical company’s stock after selling 569 shares during the period. Texas […]

Monetary Management Group Inc. lifted its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 4.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,095 shares of the biopharmaceutical company’s stock after acquiring an additional 50 shares […]

Sustainable Growth Advisers LP reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 418,581 shares of the biopharmaceutical company’s stock after selling 1,900 shares during the quarter. Regeneron Pharmaceuticals comprises […]

Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its target price raised by BMO Capital Markets from $1,055.00 to $1,082.00 in a report issued on Monday, Benzinga reports. The brokerage currently has an outperform rating on the biopharmaceutical company’s stock. A number of other brokerages have also recently weighed in on REGN. Royal Bank of Canada […]